Changeflow GovPing

What do you monitor?

Curated feeds for your role. Pick your area and get exactly the sources you need.

Recent changes

Favicon for changeflow.com

PCV2 Vaccine Patent - NDSU Research Foundation

The European Patent Office published EP4007601A2, a patent for a Porcine Circovirus Type 2 (PCV2) vaccine, granted to NDSU Research Foundation and Biological Mimetics, Inc. The patent covers vaccine compositions including live attenuated virus formulations and associated methods. Validated in 38 designated European states.

Routine Notice Pharmaceuticals
Favicon for changeflow.com

Immunotherapy Cell Patent - Memorial Sloan Kettering

The European Patent Office published patent application EP4007586A1 for Memorial Sloan Kettering Cancer Center, covering cells for improved immunotherapy and their uses. The patent designates multiple European states including DE, FR, GB, IT, NL, and others. This is a routine patent publication notice for a cancer immunotherapy technology developed by David A. Scheinberg and Leila Peraro.

Routine Notice Healthcare
Favicon for changeflow.com

Compositions and Methods for Driving T1 Event Diversity

The European Patent Office published patent application EP3930449A2 for Syngenta Crop Protection AG covering compositions and methods for driving T1 event diversity in plants. The patent application lists eight inventors and covers multiple IPC classifications including plant genetic methods and molecular biology techniques. The designated states span across European Economic Area member states.

Routine Notice Agriculture
Favicon for changeflow.com

Compositions and Methods for Treating Oculopharyngeal Muscular Dystrophy (OPMD)

The European Patent Office published patent application EP3931317A1 for Benitec IP Holdings Inc., covering compositions and methods for treating Oculopharyngeal Muscular Dystrophy (OPMD) using gene therapy vectors. The application includes four named inventors and covers therapeutic applications in the designated EPC contracting states.

Routine Notice Intellectual Property
Favicon for changeflow.com

Recombinant Bacteria Patent - National University of Singapore

The European Patent Office published application EP3930736A1, a patent for recombinant bacteria and uses thereof, filed by the National University of Singapore. The patent covers pharmaceutical applications including treatments for cancer (A61P 35/00) and inflammation (A61P 29/00). Designated states include all EU member states plus Switzerland, Norway, Iceland, Liechtenstein, Turkey, Monaco, San Marino, North Macedonia, and Serbia.

Routine Notice Intellectual Property
Favicon for changeflow.com

Methods for Treating Intracranial Hemorrhage and Assessing Efficacy

The European Patent Office published Alexion Pharmaceuticals' patent application EP3920963A1 covering methods for treating intracranial hemorrhage and assessing treatment efficacy. The application includes treatment protocols using complement inhibitors and methods for assessing therapeutic efficacy. This is a standard patent publication notice conveying no compliance requirements or deadlines.

Routine Notice Pharmaceuticals
Favicon for changeflow.com

Process for Making Stable Bacterial Extracts and Their Use as Pharmaceuticals

The European Patent Office published patent application EP3937957A1 for OM Pharma SA, covering a process for making stable bacterial extracts and their pharmaceutical applications. The A1 publication indicates the application has entered the examination phase following the search report publication. This patent relates to bacterial extract compositions with potential therapeutic uses.

Routine Notice Intellectual Property
Favicon for changeflow.com

Anti-C1S Antibody Patent Application

The European Patent Office published patent application EP3969475A1 on March 25, 2026, covering an anti-C1S antibody therapeutic developed by Chugai Seiyaku Kabushiki Kaisha. The application includes claims related to C07K 16/18 antibody compositions and A61P 25/28 (CNS/neurological applications). This publication provides notice of the patent claims and designated EU member states.

Routine Notice Pharmaceuticals
Favicon for changeflow.com

Protective cover for medical spike products

The European Patent Office published patent application EP4271317A1 for Avent, Inc., covering a protective cover for medical spike products. The patent was published March 25, 2026, with five inventors listed. The application carries IPC classifications A61M 5/00, A61M 5/162, and others related to medical devices, with designation across 39 European states including all EU member states, Switzerland, and the UK.

Routine Notice Medical Devices
Favicon for changeflow.com

Rotational Piercing Pre-Filled Medical Delivery Assembly Patent

The European Patent Office published patent EP4255366A1 for Koska Family Limited covering systems and methods for rotational piercing of pre-filled medical delivery assemblies. The patent application was filed with inventors Hanjin, Marc Andrew Koska, and Jeff Price. The designation covers 31 European member states.

Routine Notice Intellectual Property

Showing 5831–5840 of 40,786 changes

1 582 583 584 585 586 4079

Get alerts when regulations change

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.